PCSK9 Inhibitors and Cardiovascular Events

N Engl J Med. 2015 Aug 20;373(8):774-5. doi: 10.1056/NEJMc1508222.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Anticholesteremic Agents / therapeutic use*
  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, LDL / blood*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / drug therapy*
  • Male

Substances

  • Antibodies, Monoclonal
  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors